Quest Diagnostics Inc.
(You save $40.00 )
- Gift wrapping:
- Options available in Checkout
Beautifully engraved specimen certificate from the Quest Diagnostics Inc. . This historic document has an ornate border around it with vignettes of DNA, various cells, and a scientist pouring a chemical into a beaker. This item has the printed signatures of the Company's Chairman/CEO and Secretary. Quest Diagnostics is the nation's leading provider of diagnostic testing, information and services with $3.4 billion in annual revenues. The company's diagnostic testing yields information that enables health care professionals and consumers to make better decisions to improve health. Quest Diagnostics offers patients and physicians the broadest access to diagnostic testing services through its national network of approximately 30 full-service laboratories, 150 rapid response laboratories and more than 1,300 patient service centers, where specimens are collected. Quest Diagnostics is the leading provider of esoteric testing, including gene-based testing, and is the leader in routine medical testing, drugs of abuse testing, and non-hospital-based anatomic pathology testing. Quest Diagnostics empowers health care organizations and clinicians with state-of-the-art connectivity solutions that improve practice management. Through partnerships with pharmaceutical, biotechnology and information technology companies, Quest Diagnostics provides support to help speed the development of health care insights and new therapeutics. In 1967 in New York City, Dr. Paul Brown launched the clinical laboratory industry with his vision to offer high-quality, highly-automated, and cost-effective clinical testing. The business was named MetPath and it quickly became the leading independent testing laboratory in the New York area. Corning Incorporated purchased MetPath in 1982, and continued to build the company through acquisitions. The business continued to expand primarily through acquisitions, including Damon (1993), Maryland Medical Laboratory (1994) and Bioran (1994). In 1994, Corning acquired Nichols Institute, world-renowned for esoteric testing. Nichols Institute, considered the "gold standard" among many healthcare professionals, has been an important liaison between the academic, scientific and medical communities, contributing tremendous knowledge to the field of diagnostic testing, services and information. On December 31, 1996, Corning Incorporated spun off the laboratory testing business to its shareholders, establishing Quest Diagnostics as an independent company trading on the New York Stock Exchange under the Symbol "DGX". On August 16, 1999, Quest Diagnostics acquired SmithKline Beecham Clinical Laboratories (SBCL), establishing the combined company as the nation's leading provider of diagnostic testing, information and services.